Jones Elena E - OmicsDI

Show results for

Unknown (23)
Genomics (7)
Proteomics (2)
Metabolomics (2)
Transcriptomics (1)
Multiomics (1)

Organisms

Homo sapiens (8)

Repository

EGA (7)
MassIVE (2)
MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry (1)
Mass spectrometry assay (1)

Instrument Platform

Orbitrap Eclipse (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2022 (2)
2012 (1)
2013 (1)

CHEBI ID

CHEBI:10138 (1)
CHEBI:10565 (1)
CHEBI:116314 (1)
CHEBI:15354 (1)
CHEBI:15365 (1)
CHEBI:15383 (1)
CHEBI:15613 (1)
CHEBI:156331 (1)
CHEBI:15698 (1)
CHEBI:15713 (1)
CHEBI:15727, CHEBI:57485 (1)
CHEBI:15729 (1)
CHEBI:15741 (1)
CHEBI:15756 (1)
CHEBI:15760 (1)
CHEBI:15811 (1)
CHEBI:15815 (1)
CHEBI:15843 (1)
CHEBI:15873 (1)
CHEBI:15940 (1)
CHEBI:15956 (1)
CHEBI:15966, CHEBI:53375 (1)
CHEBI:16008 (1)
CHEBI:16010 (1)
CHEBI:16027 (1)
CHEBI:16031 (1)
CHEBI:16040 (1)
CHEBI:16113 (1)
CHEBI:16171 (1)
CHEBI:16175 (1)

Metabolite Name

(+)-Pyroglutamic acid (1)
(+/-)-Pipecolate (1)
(+/-)-Propionylcarnitine chloride (1)
(-)-Tetradecanoylcarnitine (1)
(10E)-12-Oxododecenoic acid (1)
(10E,12Z,15Z)-9-hydroxyoctadeca-10,12,15-trienoic acid (1)
(13S)-Hydroxyoctadecadienoate (1)
(1s,3z)-3-[(2e)-2-[(1r,3ar,7as)-7a-Methyl-1-[(2r)-6-Methylheptan-2-Yl]-2,3,3a,5,6,7-Hexahydro-1h-Inden-4-Ylidene]ethylidene]-4-Methylidene-Cyclohexan-1-Ol (1)
(2-hydroxy-3-stearoyloxy-propyl) 2-(trimethylammonio)ethyl phosphate (1)
(2E)-2-Phenyl-2-propenoic acid (1)
(2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid (1)
(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2S,3S,4R,5S)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol (1)
(2S)-1-[(2S)-2-azaniumyl-3-phenyl-propanoyl]pyrrolidine-2-carboxylate (1)
(2S)-1-[(2S)-5-amino-2-[[(2S)-2-amino-4-methyl-pentanoyl]amino]-5-keto-pentanoyl]proline (1)
(2S)-2-(methylamino)Pentanedioic acid (1)
(2S)-2-Amino-3-methylbutanoic acid (1)
(2S)-2-[[(4S)-4-amino-4-carboxy-butanoyl]amino]-4-methyl-pentanoic acid (1)
(2S)-2-amino-5-[[(1S)-1-carboxy-2-methyl-propyl]amino]-5-oxo-pentanoic acid (1)
(2S)-3-(5-mercapto-3-methyl-imidazol-4-yl)-2-(methylammonio)propionate (1)
(2S,3R)-(-)-Threonine (1)
(2S,3R)-2-[[[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]-oxomethyl]amino]-3-hydroxybutanoic acid (1)
(2S,3S)-alpha-Amino-beta-merthyl-n-valerate (1)
(2S,3S,4R)-2-aminohexadecane-1,3,4-triol (1)
(3R)-3-[(Z)-octadec-9-enoyl]oxy-4-(trimethylazaniumyl)butanoate (1)
(3R,3'S)-3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione (1)
(3S,6S)-3-Benzyl-6-(2-methylpropyl)piperazine-2,5-dione (1)
(4S)-4-amino-5-[[(1S)-1-carboxyethyl]amino]-5-keto-valeric acid (1)
(6R)-6-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid (1)
(9Z)-octadec-9-enamide (1)
(9Z,12Z)-octadeca-9,12-dienoic acid [1-(anilinomethyl)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-ethyl] ester (1)

Study type

Transcription profiling by array (1)

Release Date

2021 (4)
2024 (3)
2012 (2)
2025 (2)
2023 (2)
2018 (2)
2016 (2)
2011 (2)
2022 (1)
2020 (1)
2019 (1)
2017 (1)
2014 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Systematic Discovery of TLR Signaling Components Delineates Viral-Sensing Circuits.

Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, Ciaccio MF, Gat-Viks I, Tonti E, DeGrace MM, Clauser KR, Garber M, Eisenhaure TM, Yosef N, Robinson J, Sutton A, Andersen MS, Root DE, von Andrian U, Jones RB, Park H; Carr SA, Regev A, Amit I, Hacohen N. Cell, 2011, 147(4) 853-867. doi: 10...

2013-12-10 | MSV000078507 | MassIVE

Experimental and computational approaches for deep metabolome annotation with application to the ecotoxicological model organism Daphnia magna

Identifying metabolomes with greater coverage and confidence is a critical step towards interpreting the metabolic basis of human and environmental health. Yet for over two decades the field of metabolomics has been inhibited by limited metabolite identification. To address this, we developed the...

MTBLS2273 | MetaboLights

Electrostatic complementarity at the interface drives transient protein-protein interactions.

Not available

S-EPMC10290103 | biostudies-literature

Antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19

BACKGROUND: There is a critical need for rapid viral infection diagnostics to enable prompt case identification in pandemic settings and support targeted antimicrobial prescribing.

METHODS: Using untargeted high-resolution liquid chromatography coupled with...

2022-02-10 | MTBLS718 | MetaboLights

Use of virulence determinants and seropathotypes to distinguish high- and low-risk Escherichia coli O157 and non-O157 isolates from Europe.

Not available

S-EPMC9161224 | biostudies-literature

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.

Not available

S-EPMC5368596 | biostudies-literature

Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson's disease model.

Supporting data for "Disruption of lysosomal proteolysis in astrocytes facilitates midbrain proteostasis failure in an early-onset PD model", DOI: T.B.D. Related to Figure 4A and S4A-B. KN43-66 - TMTpro | 4plex | Whole cell proteome - MS3 KN67-72 - TMTpro | 4plex | Enriched Phospho-peptides - MS2 K...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2022-08-24 | MSV000090202 | MassIVE

MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.

Not available

S-EPMC9205050 | biostudies-literature

Blood mRNA expression signatures derived from unsupervised analyses identify prostate cancers with poor outcome

Background: Inter-patient prostate cancer (PrCa) heterogeneity results in highly variable patient outcomes. Multi-purpose biomarkers to dissect this heterogeneity are urgently required to improve treatment and accelerate drug development in PrCa. Circulating biomarkers are most practical for evaluat...

ORGANISM(S): Homo sapiens

2012-10-15 | E-GEOD-37199 | biostudies-arrayexpress

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Not available

S-EPMC11318912 | biostudies-literature

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

35 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets